Infective Endocarditis of the Aortic Valve with Anterior Mitral Valve Leaflet Aneurysm by Tomsic, A. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/172807
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
Texas Heart Institute Journal • Aug. 2016, Vol. 43, No. 4 http://dx.doi.org/10.14503/THIJ-15-5322      345
© 2016 by the Texas Heart ® 
Institute, Houston
Infective Endocarditis 
of the Aortic Valve with 
Anterior Mitral Valve 
Leaflet Aneurysm
Mitral valve leaflet aneurysm is a rare and potentially devastating complication of aortic 
valve endocarditis. We report the case of a 48-year-old man who had endocarditis of the 
native aortic valve and a concomitant aneurysm of the anterior mitral valve leaflet. Severe 
mitral regurgitation occurred after the aneurysm perforated. The patient showed no signs of 
heart failure and completed a 6-week regimen of antibiotic therapy before undergoing suc-
cessful aortic and mitral valve replacement. In addition to the patient’s case, we review the 
relevant medical literature. (Tex Heart Inst J 2016;43(4):345-9)
M itral valve (MV) aneurysms are rare and are most often associated with infective endocarditis (IE) of the aortic valve (AV). Possible mechanisms include regurgitant infectious flow from the AV, direct contact with AV 
vegetation, and direct spread across adjacent structures, such as the mitral–aortic in-
tervalvular fibrous body.1,2 Such an aneurysm poses a threat for septic embolization or 
aneurysm rupture. Acute, severe MV regurgitation and hemodynamic deterioration 
can follow, often necessitating urgent surgery.3 Current guidelines on the optimal 
timing of surgery in IE suggest urgent treatment when signs of uncontrolled infection 
are present, including abscess formation, fistula formation, enlarging vegetation, and 
pseudoaneurysm formation.4 However, there is no consensus about optimal treatment 
when MV-leaflet aneurysms form. To our knowledge, only 29 cases of MV-leaflet 
aneurysm associated with IE have been reported (Table I1,3,5-12), including that of our 
patient. Of these patients, 75% underwent surgical treatment, usually because of 
severe MV regurgitation caused by perforation of the MV aneurysm.
 We present here a case of native AV endocarditis complicated by anterior MV-leaflet 
(AMVL) aneurysm formation and subsequent severe MV regurgitation caused by 
aneurysm perforation. In addition, we review the relevant medical literature.
Case Report
In August 2014, a 48-year-old man was referred to our center. He presented with a 
2-month history of fever, fatigue, and dry cough. Blood analysis yielded a moder-
ately elevated C-reactive protein (CRP) level and white blood cell (WBC) count. 
An electrocardiogram revealed a prolonged PR interval. A chest radiograph showed 
nothing unusual. The patient reported no obvious risk factors for IE. A transthoracic 
echocardiogram (TTE) revealed a bicuspid AV with a small vegetation (<1 cm) 
accompanied by severe aortic regurgitation. In addition, vegetations were observed 
on the AMVL, with minimal mitral regurgitation. The patient’s left ventricular 
function was normal. Streptococcus gordonii species was isolated from blood cultures, 
and antibiotic therapy with intravenous gentamicin and benzylpenicillin was initi-
ated. After 4 days of therapy, a transesophageal echocardiogram (TEE) showed an 
aneurysm of the noncoronary cusp of the AV, an AMVL aneurysm, and trace mitral 
insufficiency (Fig. 1). The patient showed no signs of heart failure and his CRP level 
and WBC count were decreasing, so we decided to continue the antibiotic therapy 
and to delay surgery. We closely monitored the patient by means of repeated blood 
analyses and TTE.
 Despite weeks of antibiotic therapy, the patient experienced fever, pain in the left 
thigh, and a higher CRP level and WBC count. A TTE revealed a newly developed 
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perforation of the AMVL aneurysm, accompanied by 
severe mitral regurgitation with an eccentric regurgi-
tant jet (Fig. 2). No new vegetations were observed. The 
results of a positron emission tomographic-computed 
tomographic scan revealed a peripheral embolism in 
the deep femoral artery; the heart showed no signs of 
inflammation or failure. After a few days, the patient’s 
CRP level and WBC count decreased, and the pain 
in his left thigh resolved. He underwent surgery after 
completing a 6-week regimen of antibiotic therapy.
 Intraoperatively, a large, ruptured aneurysm was no-
ticed on the AMVL, accompanied by signs of active 
inflammation (Fig. 3). Successful MV repair was un-
likely, so we replaced the MV with a 29-mm mechani-
cal prosthesis (St. Jude Medical, Inc.; St. Paul, Minn). 
The bicuspid AV was severely damaged, and swelling of 
the aortic annulus was noted without active involvement 
of the intervalvular fibrous body. We replaced the AV 
with a 21-mm mechanical prosthesis (St. Jude Medical). 
Perioperative TEE showed excellent prosthetic-valve 
function without paravalvular leakage. Intraoperative 
cultures were negative, and results of a pathologic ex-
amination suggested a resolving infection. The patient 
recovered uneventfully and was discharged to another 
institution to complete the postoperative antibiotic regi-
men (6 wk benzylpenicillin and 2 wk gentamicin). At 
his 6-month evaluation, the patient had no signs of re-
current infection.
Discussion
Our patient had native AV endocarditis, accompanied 
by aneurysms of the AMVL and the noncoronary cusp 
of the AV. Although the AMVL aneurysm perforated 
after several weeks of therapy, no signs of heart failure 
were observed during the course of treatment. The pa-
tient underwent successful surgery after he had com-
pleted a full 6-week course of antibiotic therapy.
 Mitral valve aneurysms are rare, with an incidence of 
0.2% to 0.3% on echocardiographic examinations in 
general.5,11 Of the several causative mechanisms reported 
for MV aneurysm (among them connective-tissue dis-
orders, pseudoxanthoma elasticum, and myxomatous 
valve degeneration), IE is the most prevalent.5,8,11 To our 
knowledge, only 28 previous cases of MV aneurysms 
caused by IE have been reported (Table I).
 Anterior MV-leaflet aneurysms in IE develop as in-
fection progresses, involves the MV leaflet, forms an ab-
scess, and causes local weakening of underlying tissue. 
This last is responsible for tissue-bulging and eventu-
ally aneurysm formation.5 Further destruction of leaf-
let tissue often leads to perforation with accompanying 
regurgitation and possibly peripheral embolization.3 
Aneurysm perforation occurred in 72% of the reported 
cases. Guler and colleagues11 affirmed that larger aneu-
rysm size does not necessarily correlate with a higher risk 
of perforation. The moment of aneurysm perforation 
might be a crucial point for peripheral embolization, 
as in our patient when the timing of peripheral embo-
lization correlated with echocardiographic evidence of 
aneurysm perforation. Peripheral embolization was seen 
in 18.2% (2/11) of the patients who had perforated an-
eurysms (Table I).
Fig. 1  Transesophageal echocardiogram shows an aneurysm 
of the noncoronary cusp of the aortic valve (arrow) and an 
aneurysm of the anterior mitral valve leaflet (arrowhead).
Fig. 2  Transthoracic echocardiogram shows rupture of the 
anterior mitral valve leaflet aneurysm (arrow) with an eccentric 
regurgitant jet (arrowhead).
Fig. 3  Intraoperative photograph shows the mitral valve and the 
aneurysm of the inflamed anterior mitral leaflet (arrow). Rupture 
of the aneurysm is seen (arrowhead).
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 The optimal timing of surgery in IE is a matter of de-
bate. Three indications for urgent surgical intervention 
are large vegetations posing a threat of embolization, 
signs of heart failure, and signs of uncontrolled infec-
tion.4 In MV aneurysm without the aforementioned 
observations, there is little consensus on a preferred 
course of therapy. In the reported cases of IE with MV 
aneurysms (Table I), most patients (75%) ultimately 
underwent surgical treatment, although the timing of 
surgery was usually unclear. Ruparelia and associates8 
suggested planning surgery as soon as the abnormality 
is observed, in order to prevent aneurysm rupture, the 
development of severe mitral regurgitation, and embo-
lization. On the other hand, Vilacosta and co-authors5 
suggested the possibility of conservative management, 
with surgical intervention only in case of cardiac dete-
rioration. Other authors have recommended a similar 
approach.7,10,12
 Early surgery for IE has been advocated in general. 
The authors of several case series have reported that, in 
comparison with conventional treatment, early surgical 
treatment yields improved long-term outcomes and less 
risk of peripheral embolization.13-16 This was verif ied 
in a small randomized clinical trial that included 76 
patients who had left-sided IE and vegetations >10 mm 
in size.13 No differences were found in 6-month mor-
tality rates. However, early surgery (within 48 hr after 
randomization) was associated with a signif icantly 
lower embolic-risk rate (21% vs 3%).13 Funakoshi and 
colleagues14 retrospectively studied 212 patients with 
left-sided IE who had undergone surgery. The in-hos-
pital mortality rate (5% vs 13%) was lower after early 
surgery versus late surgery, and the respective 7-year 
survival rate (94% vs 82%) was higher. However, the 
above studies chiefly included patients who had large 
vegetations—a known risk factor for repeated embo-
lization. Furthermore, patients were usually divided 
into early-surgical and conventional-treatment groups; 
the conventional groups were heterogeneous, including 
patients who underwent late surgery and patients who 
were treated conservatively. Few studies have actually 
compared outcomes between early and late surgical 
intervention. Funakoshi and colleagues14 did not find 
benefits in early surgical intervention when comparing 
only patients who underwent surgery (late surgery was 
defined as >2 wk after the initial diagnosis). Statisti-
cally significant decreases in aortic root surgery (1% vs 
7%) and shorter aortic cross-clamp times (106 vs 132 
TABLE I. Reported Cases of Aortic Valve Infective Endocarditis with Mitral Leaflet Aneurysm
 
Reference
Pt. 
No.
Age (yr), 
Sex
Heart  
Failure
Embo-
lism
Perfora-
tion
Infective  
Organism
Mitral 
Leaflet
 
AR
 
MR
 
Surgery
Vilacosta I, et al.5 
(1999)
1 24, M Yes No Yes Culture-negative Anterior Severe Severe MVR*
2 22, M No Yes No Staphylococcus 
aureus
Anterior Moderate None None
3 22, M Yes No Yes S. aureus Posterior None Moderate None
4 33, F Yes No Yes Culture-negative Anterior None Severe MVR*
5 40, F No No Yes Culture-negative Posterior None Severe MVR*
6 50, M Yes No Yes Q fever Anterior Severe Severe MVR*
7 55, F Yes No Yes Enterococcus Anterior Severe Severe MVR*
8 22, M Yes No No S. aureus Anterior Severe None None
9 40, M Yes No Yes S. aureus Anterior Severe Severe MVR*
10 55, F Yes Yes Yes Enterococcus Anterior Moderate Severe MVR*
11 65, F No No No Culture-negative Anterior None None None
Marcos-Alberca 
P, et al.6 (2000)
12 78, M Yes No No Streptococcus 
sanguis
Anterior Severe None AVR, MVP
Gao C, et al.7 
(2004)
13 37, M Yes No No Culture-negative Anterior Severe Moderate AVR, MVR
Ruparelia N,  
et al.8 (2011)
14 42, M No No NR Coagulase-negative 
Staphylococcus
Anterior Severe Mild AVR, MVR
Stechert MM,  
et al.1 (2012)
15 50, M Yes NR No Streptococcus 
viridans
Anterior Severe Moderate AVR, MVP
Subban V, et al.9 
(2012)
16 28, M Yes NR NR Culture-negative Posterior NR Severe Died before 
operation
Continues on next page
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min) were observed after late versus early surgery. This 
might indicate technical diff iculties associated with 
weak and infected tissue when operating in the early 
phase of endocarditis. Furthermore, in a retrospective 
study of 129 patients who had left-sided IE, late sur-
gery (>11 d after diagnosis) yielded a lower 6-month 
mortality rate.17 The conclusions were not statistically 
significant; however, the hazard ratio was in the protec-
tive direction for late surgery. The lowest hazard ratio 
was reported for the patients who underwent surgery 
latest after diagnosis.
 When planning surgery in complicated aortic valve 
IE, surgeons should consider possible extravalvular in-
volvement, in particular the aortic root and the mitral–
aortic intervalvular f ibrous body. In our patient, this 
would have necessitated an extensive operation, includ-
ing aortic root and MV replacement with reconstruc-
tion of the intervalvular f ibrous body. This high-risk 
procedure has a reported intraoperative mortality rate 
of 10% to 16%.18,19 Antibiotic therapy before surgery 
enabled our patient’s intervalvular f ibrous body to be 
preserved. We think that simplifying operations is an 
important benefit of presurgical antibiotic therapy, be-
cause less extensive surgery is clearly associated with less 
operative risk. Given the extent of abnormalities associ-
ated with MV-leaflet aneurysm development, surgical 
MV replacement is often necessary; however, repair 
should be performed if possible, because of the lower 
risk of recurrent IE.14,20
 The probability of peripheral embolism in AMVL 
aneurysm seems to be reasonably low, given its reported 
occurrence (Table I). The investigators of 1,456 cases of 
IE reported an embolization rate of 34.3%; most em-
bolic events occurred before or during the first week of 
antibiotic therapy. After one week of therapy, surgery 
did not seem to provide sufficient benefit in preventing 
embolization.21 In our patient, who had a good response 
to therapy, the risk of peripheral embolism was less than 
that of extensive surgery.
 Conservative management before surgical interven-
tion for IE with AMVL aneurysm, with or without 
perforation, can be both safe and beneficial, enabling 
healing and recovery of infected tissue and possibly 
avoiding unnecessarily extensive surgical procedures. 
However, when signs of heart failure are present, urgent 
surgery becomes advisable.
 
Reference
Pt. 
No.
Age (yr), 
Sex
Heart  
Failure
Embo-
lism
Perfora-
tion
Infective  
Organism
Mitral 
Leaflet
 
AR
 
MR
 
Surgery
Jackson G, et al.3 
(2013)
17 35, M Yes Yes NR Streptococcus  
sanguinis
Anterior Severe Mild Aortic root 
repair, AVR, 
MVP
Kharwar RB, et 
al.10 (2014)
18 30, M Yes No Yes S. aureus Anterior Severe Severe AVR, MVP
Guler A, et al.11 
(2014)
19 48, M NR NR Yes S. viridans Anterior Moderate Severe AVR, MVR
20 66, F NR NR Yes Culture-negative Anterior Severe Severe AVR, MVR
21 26, M NR NR Yes Enterococcus Anterior None Severe None
22 32, M NR NR Yes S. aureus Anterior Severe Severe AVR, MVR
23 21, F NR NR No S. aureus Anterior Severe Trace AVR, MVR, 
TVP
24 69, M NR NR Yes Culture-negative Anterior Mild Moderate None
25 64, M NR NR Yes S. aureus Posterior None Severe MVR
26 59, M NR NR Yes S. aureus Anterior Moderate Severe AVR, MVR
27 57, M NR NR Yes Culture-negative Anterior Mild Severe AVR, MVR
Eiseman MS,  
et al.12 (2014)
28 61, M No No Yes S. viridans Anterior Moderate Severe AVR, MVR
Current case 29 48, M No Yes Yes Streptococcus 
gordonii
Anterior Severe Severe AVR, MVR
 
AR = aortic regurgitation; AVR = aortic valve replacement; F = female; M = male; MR = mitral regurgitation; MVP = mitral valve plasty; 
MVR = mitral valve replacement; NR = not reported; Pt = patient; TVP = tricuspid valve plasty 
 
* Vilacosta and colleagues5 reported that 6 of 8 surgical patients (including one with no clinical history of infective endocarditis, not 
included in Table I) also needed AVR. The authors did not specify the patients to whom this applied.
TABLE I Continued. Reported Cases of Aortic Valve Infective Endocarditis with Mitral Leaflet Aneurysm
Texas Heart Institute Journal Aortic IE with Anterior MV Leaflet Aneurysm      349
References
  1. Stechert MM, Pletcher JR, Tseng EE, London MJ. Echo 
rounds: aneurysm of the anterior mitral valve. Anesth Analg 
2012;114(1):86-8.
  2. Al-Refai MA, Oueida FM, Lui RC, Al-Saif SM, Al-Omran 
HM. Impressive echocardiographic images of a rare pathol-
ogy: aneurysm of the mitral valve - report of two cases and 
review of the literature. J Saudi Heart Assoc 2013;25(1):47-
51.
  3. Jackson G, Camargo C, Ling LF, Kalahasti V, Rimmerman 
CM. The clinical picture: fever, dyspnea, and a new heart 
murmur. Cleve Clin J Med 2013;80(9):559-61.
  4. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vi-
lacosta I, et al. Guidelines on the prevention, diagnosis, and 
treatment of infective endocarditis (new version 2009): the 
Task Force on the Prevention, Diagnosis, and Treatment of 
Infective Endocarditis of the European Society of Cardiol-
ogy (ESC). Endorsed by the European Society of Clinical 
Microbiology and Infectious Diseases (ESCMID) and the In-
ternational Society of Chemotherapy (ISC) for Infection and 
Cancer. Eur Heart J 2009;30(19):2369-413.
  5. Vilacosta I, San Roman JA, Sarria C, Iturralde E, Graupner 
C, Batlle E, et al. Clinical, anatomic, and echocardiographic 
characteristics of aneurysms of the mitral valve. Am J Cardiol 
1999;84(1):110-3, A9.
  6. Marcos-Alberca P, Rey M, Serrano JM, Fernandez-Rozas I, 
Navarro F, Contreras A, Rabago R. Aneurysm of the anterior 
leaflet of the mitral valve secondary to aortic valve endocardi-
tis. J Am Soc Echocardiogr 2000;13(11):1050-2.
  7. Gao C, Xiao C, Li B. Mitral valve aneurysm with infective 
endocarditis. Ann Thorac Surg 2004;78(6):2171-3.
  8. Ruparelia N, Lawrence D, Elkington A. Bicuspid aortic valve 
endocarditis complicated by mitral valve aneurysm. J Card 
Surg 2011;26(3):284-6.
  9. Subban V, Krishnamurthy V, Mohanraj A, Ajit MS. Posterior 
mitral leaflet aneurysm - a rare cause of mitral regurgitation. 
Indian Heart J 2012;64(4):402-3.
10. Kharwar RB, Mohanty A, Sharma A, Narain VS, Sethi R. 
Ruptured anterior mitral leaflet aneurysm in aortic valve in-
fective endocarditis--evaluation by three-dimensional echo-
cardiography. Echocardiography 2014;31(3):E72-6.
11. Guler A, Karabay CY, Gursoy OM, Guler Y, Candan O, 
Akgun T, et al. Clinical and echocardiographic evaluation of 
mitral valve aneurysms: a retrospective, single center study. 
Int J Cardiovasc Imaging 2014;30(3):535-41.
12. Eiseman MS, Schroeder AR, Rutkowski PS, Rashid ZA, 
Pagel PS. An unusual cause of severe mitral regurgitation in 
a patient with aortic valve endocarditis. J Cardiothorac Vasc 
Anesth 2014;28(5):1432-4.
13. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, et 
al. Early surgery versus conventional treatment for infective 
endocarditis. N Engl J Med 2012;366(26):2466-73.
14. Funakoshi S, Kaji S, Yamamuro A, Tani T, Kinoshita M, 
Okada Y, Furukawa Y. Impact of early surgery in the active 
phase on long-term outcomes in left-sided native valve infec-
tive endocarditis. J Thorac Cardiovasc Surg 2011;142(4):836-
842.e1.
15. Kim DH, Kang DH, Lee MZ, Yun SC, Kim YJ, Song JM, et 
al. Impact of early surgery on embolic events in patients with 
infective endocarditis. Circulation 2010;122(11 Suppl):S17-
 22.
16. Delahaye F. Is early surgery beneficial in infective endocardi-
tis? A systematic review. Arch Cardiovasc Dis 2011;104(1):35-
44.
17. Tleyjeh IM, Steckelberg JM, Georgescu G, Ghomrawi HM, 
Hoskin TL, Enders FB, et al. The association between the 
timing of valve surgery and 6-month mortality in left-sided 
infective endocarditis [published erratum appears in Heart 
2008;94(11):1496]. Heart 2008;94(7):892-6.
18. David TE, Kuo J, Armstrong S. Aortic and mitral valve re-
placement with reconstruction of the intervalvular f ibrous 
body. J Thorac Cardiovasc Surg 1997;114(5):766-72.
19. De Oliveira NC, David TE, Armstrong S, Ivanov J. Aortic 
and mitral valve replacement with reconstruction of the in-
tervalvular f ibrous body: an analysis of clinical outcomes. J 
Thorac Cardiovasc Surg 2005;129(2):286-90.
20. Shang E, Forrest GN, Chizmar T, Chim J, Brown JM, Zhan 
M, et al. Mitral valve infective endocarditis: benefit of early 
operation and aggressive use of repair. Ann Thorac Surg 2009; 
87(6):1728-34.
21. Rizzi M, Ravasio V, Carobbio A, Mattucci I, Crapis M, Stel-
lini R, et al. Predicting the occurrence of embolic events: an 
analysis of 1456 episodes of infective endocarditis from the 
Italian Study on Endocarditis (SEI). BMC Infect Dis 2014; 
14:230.
